Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960043/S139

Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

Abbott Vascular, Inc. · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONP960043/S139

What did the FDA decide?

FDA’s entry is a supplement to PMA P960043, not a new PMA for the closure systems. The database record identifies the products as Perclose ProGlide Suture-Mediated Closure System and Perclose ProStyle Suture-Mediated Closure and Repair System, and the decision type is a 30-Day Notice.

The described change is limited to manufacturing operations: adding a location for the cuff swaging process in another suite within the same facility. The supplied record does not describe any new indication, clinical data, performance change, or device design change; it only states the process-location change.

FDA approval order statement

adding a location for the cuff swaging process used for Perclose ProGlide Suture-Mediated Closure System and Perclose ProStyle Suture-Mediated Closure and Repair System in another suite in the same facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960043/S139
Regulatory pathway
PMA supplement
Product code
MGB
Decision code
OK30
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

For the original device and its historical approval scope, see PMA P960043. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960043 · Original PMA

    PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM

  2. P960043/S137 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  3. P960043/S139 received

    Application receipt date recorded by FDA.

  4. P960043/S138 · Related supplement

    Perclose ProStyle Suture-Mediated Closure and Repair System

  5. P960043/S139 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P960043. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960043

Explore the linked device profile

Other records with product code MGB

Product / regulatory recordCompanyPathwayDecision dateSource
Vasorum, Ltd.PMA supplementOct 30, 2026FDA
Vivasure Medical , Ltd.PMA approvalOct 16, 2026FDA
Cardiva Medical, Inc.PMA supplementSep 10, 2026FDA
Vasorum, Ltd.PMA approvalJul 20, 2016FDA
Cardiva Medical, Inc.PMA approvalJan 31, 2013FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
400 Saginaw Dr., Redwood, CA, 94063

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records